Richard N Channick - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Richard N Channick

Showing results (101-110 of 106) with videos related to

Pageof 11

Sort By:

You have reached the last page of results.This site can display upto 106 results.

Circulation|April 22, 2009

A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertensionYing Yu, Steve H Keller, Carmelle V Remillard, et al.

American Journal of Respiratory and Critical Care Medicine|May 8, 2026

Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial HypertensionRobin Osterhout, Athénaïs Boucly, Raymond L Benza, et al.

European Heart Journal. Acute Cardiovascular Care|February 13, 2024

Modelling costs of interventional pulmonary embolism treatment: implications of US trends for a European healthcare systemKatharina Mohr, Brent Keeling, Klaus Kaier, et al.

Advances in Therapy|August 11, 2025

Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension StudyOlivier Sitbon, Sandeep Sahay, Pilar Escribano Subías, et al.

The Lancet. Respiratory Medicine|May 5, 2024

Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trialRobert P Frantz, Vallerie V McLaughlin, Sandeep Sahay, et al.

American Journal of Respiratory and Critical Care Medicine|February 1, 2021

NEDD9 Is a Novel and Modifiable Mediator of Platelet-Endothelial Adhesion in the Pulmonary CirculationGeorge A Alba, Andriy O Samokhin, Rui-Sheng Wang, et al.

Pageof 11

Search research articles

Showing results (101-110 of 106) with videos related to

Sort By:

Pageof 11

You have reached the last page of results.This site can display upto 106 results.

Circulation|April 22, 2009

A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertensionYing Yu, Steve H Keller, Carmelle V Remillard, et al.

American Journal of Respiratory and Critical Care Medicine|May 8, 2026

Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial HypertensionRobin Osterhout, Athénaïs Boucly, Raymond L Benza, et al.

European Heart Journal. Acute Cardiovascular Care|February 13, 2024

Modelling costs of interventional pulmonary embolism treatment: implications of US trends for a European healthcare systemKatharina Mohr, Brent Keeling, Klaus Kaier, et al.

Advances in Therapy|August 11, 2025

Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension StudyOlivier Sitbon, Sandeep Sahay, Pilar Escribano Subías, et al.

The Lancet. Respiratory Medicine|May 5, 2024

Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trialRobert P Frantz, Vallerie V McLaughlin, Sandeep Sahay, et al.

American Journal of Respiratory and Critical Care Medicine|February 1, 2021

NEDD9 Is a Novel and Modifiable Mediator of Platelet-Endothelial Adhesion in the Pulmonary CirculationGeorge A Alba, Andriy O Samokhin, Rui-Sheng Wang, et al.

Pageof 11